[Pefloxacin in the treatment of recurrent urinary tract infections].
Thirty-seven patients with relapsing infections of the urinary tract were treated with pefloxacine, 400 mg/12 h for a period of 7-28 days. The clinical success of treatment was 100%, the bacteriological success 95%. Within 3-4 weeks after termination of treatment 63% of the patients did not develop a relapse, in particular those who did not have morphological changes of the kidneys. Side-effects-gastrointestinal, nervous, dermatological--during treatment were not severe. The results are comparable with results of the effect of ofloxacine in a similar group of patients.
Centrum klinickej farmakológie Výskumného ústavu lekárskej bioniky, Bratislava.
A
A
Oksa
V
V
Dzúriková
M
M
Gajdos
A
A
Krechnáková
G
G
Krivosíková
C
C
Ploczeková
V
V
Spustová
D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015242:Ofloxacin / Q000627:therapeutic use; D015366:Pefloxacin / Q000009:adverse effects / Q000627:therapeutic use*; D012008:Recurrence; D014552:Urinary Tract Infections / Q000188:drug therapy*
D015366:Pefloxacin; D015242:Ofloxacin
Pefloxacín v liecbe recidivujúcich infekcií mocových ciest.